Page last updated: 2024-11-05

ticlopidine and Kahler Disease

ticlopidine has been researched along with Kahler Disease in 1 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Research Excerpts

ExcerptRelevanceReference
" clopidogrel) is known to be essential in patients in whom percutaneous coronary intervention with stent implantation has been performed in order to prevent stent thrombosis and its fatal consequences."3.77[Diagnostic laparoscopy under dual antiplatelet therapy with clopidogrel and aspirin]. ( Buerke, M; Mannes, F; Plehn, A; Schlitt, A; Vogt, A; Werdan, K; Wolf, HH, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vogt, A1
Schlitt, A1
Buerke, M1
Mannes, F1
Wolf, HH1
Werdan, K1
Plehn, A1

Other Studies

1 other study available for ticlopidine and Kahler Disease

ArticleYear
[Diagnostic laparoscopy under dual antiplatelet therapy with clopidogrel and aspirin].
    Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2011, Volume: 106, Issue:1

    Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Diagnosis, Differential; Drug Substituti

2011